TickerFacts.

Company research / BIXT

Bioxytran, Inc (BIXT)

Build a valuation ↗↓ Download CSV

SEC name BIOXYTRAN, INC · CIK 0001445815 · OTC · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated NV
  • Fiscal year ends Dec 31

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 10-Q (quarterly report) · 2026-08-14

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

Period ended2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenuen/an/an/an/an/an/an/an/a$191.1K$246.5K
Cost of Revenuen/an/an/an/an/an/an/an/a$104.0K$96.3K
Gross Profitn/an/an/an/an/an/an/an/a$87.1K$150.2K
R&D Expense$454.0K$112.3K$1.15M$1.28M$2.01M$544.5Kn/an/an/an/a
Operating Income-$1.84M-$2.22M-$3.80M-$2.44M-$4.21M-$1.27M-$1.63M-$215.1K-$310.6K-$671.3K
Net Income-$2.12M-$2.37M-$4.47M-$2.47M-$4.03M-$2.54M-$1.86M-$296.4K-$318.4K-$696.8K
EPS (Diluted)-$0.02-$0.02-$0.03-$0.02n/an/an/an/an/an/a
Total Assets$658.6K$138.7K$139.4K$370.9K$119.3K$326.4K$219.6K$36.4K$110$51.7K
Total Liabilities$3.25M$1.93M$3.24M$3.67M$3.28M$2.27M$1.02M$261.7K$1.4K$342.3K
Shareholders' Equity-$2.59M-$1.79M-$3.10M-$3.30M-$3.16M-$1.94M-$799.3K-$225.3K-$1.3K-$290.6K
Cash & Equivalentsn/an/an/an/an/an/an/an/an/a$11.1K
Operating Cash Flow-$526.5K-$381.3K-$775.4K-$1.80M-$1.70M-$1.10M-$431.0K-$185.9K-$18.5K-$42.4K
Shares Outstanding108.15M86.78M144.64M123.35M110.84M97.45M86.48M85.10M85.10M28.17M
Weighted Average Diluted Shares91.84M138.60M133.97M112.71Mn/an/an/an/an/an/a
EPS (Basic)-$0.02-$0.02-$0.03-$0.02-$0.04n/an/an/an/an/a